Profile data is unavailable for this security.
About the company
PT Kimia Farma Tbk is an Indonesia-based company, which is engaged in producing pharmaceutical products, such as medicines, active pharmaceutical ingredients, traditional medicines, and cosmetics. The Company produces medical devices and chemical materials. The Company is also involved in producing vegetable oil, iodine, and salts. Its products include Glucokaf, Diazink, Oracef, Kifarox, Magacid Suspension, Magaside Chewable Tablets, Nitrocafe Retarded, Nitrocafe Retard Forte, Trinolon, Raistine, VAGIZOL, Neviral, Hiviral Tablet, Duviral, Codipront Cum Expectorant, RETHAPHYL SR, and SUPRAFLU. Its generic products include PETHIDIN Hcl, PARACETAMOL, Diclofenac Sodium, MEPHANAMIC ACID, ANTALGIN, ANTASIDE DOEN, PYRANTEL, ALBENDAZOLE, METRONIDAZOLE TABLET, NEO BLOOD ADDING TABLET, FERROUS SULOATE SYRUP, DIMENHYDRINATE, ACYCLOVIR, AMBROXOL HCL, CHLOROQUINE, CHLORPROMAZINE HCL, CODEIN, CLOPIDOGREL, ERGOTAMINE COFFEE, METHYLERGOMETRINE TABLET SALUTE, MELOXICAM, and Pherphenazine.
- Revenue in IDR (TTM)10.50tn
- Net income in IDR-180.60bn
- Incorporated1971
- Employees11.51k
- LocationKimia Farma Tbk PTJalan Veteran No. 9JAKARTA 10110IndonesiaIDN
- Phone+62 213847709
- Fax+62 213814441
- Websitehttp://www.kimiafarma.co.id
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Merck Tbk PT | 1.15tn | 163.62bn | 2.15tn | 393.00 | 13.17 | 2.97 | 11.34 | 1.88 | 365.22 | 365.22 | 2,561.49 | 1,621.14 | 1.22 | 2.16 | 8.41 | 2,980,644,000.00 | 17.45 | 7.22 | 21.69 | 10.91 | 37.78 | 39.04 | 14.26 | 9.53 | 1.92 | 34.45 | 0.0235 | 426.22 | 62.29 | 0.5654 | 83.11 | -3.07 | 11.07 | -2.69 |
| Indofarma Tbk PT | 2.31tn | -223.52bn | 2.18tn | 1.18k | -- | 6.72 | -- | 0.9463 | -72.15 | -72.15 | 745.51 | 104.92 | 1.11 | 6.05 | 5.69 | 1,842,803,000.00 | -10.77 | -1.40 | -23.64 | -2.79 | 1.35 | 17.81 | -9.68 | -1.18 | 0.9242 | -3.14 | 0.5993 | -- | 69.15 | 11.62 | -136,356.00 | -- | -18.53 | -- |
| Darya-Varia Laboratoria Tbk PT | 1.86tn | 43.95bn | 2.21tn | 1.26k | 50.32 | 1.52 | 20.61 | 1.19 | 39.25 | 39.25 | 1,657.99 | 1,300.03 | 0.8719 | 2.22 | 2.66 | 1,498,745,000.00 | 2.06 | 9.98 | 2.72 | 13.52 | 52.33 | 53.53 | 2.37 | 10.13 | 2.18 | -- | 0.0018 | 67.95 | 3.89 | 5.54 | -9.47 | -0.7147 | -14.99 | 11.89 |
| Kimia Farma Tbk PT | 10.50tn | -180.60bn | 5.17tn | 11.51k | -- | 0.7165 | 19.74 | 0.4928 | -32.52 | -32.52 | 1,890.12 | 1,297.92 | 0.5598 | 2.19 | 4.54 | 881,718,000.00 | -1.01 | 1.82 | -1.64 | 3.00 | 33.85 | 36.28 | -1.80 | 2.55 | 0.5965 | 0.5404 | 0.5492 | 24.79 | 28.50 | 17.21 | 1,613.68 | 2.48 | 12.14 | 11.14 |
| Tempo Scan Pacific Tbk PT | 11.98tn | 818.70bn | 6.29tn | 4.55k | 7.62 | 0.9196 | 5.51 | 0.5252 | 183.00 | 183.00 | 2,679.31 | 1,516.93 | 1.18 | 4.34 | 9.26 | 2,535,298,000.00 | 8.48 | 8.33 | 11.51 | 11.46 | 34.26 | 37.20 | 7.16 | 6.44 | 1.85 | -- | 0.1604 | 36.32 | 2.43 | 4.22 | 4.57 | 8.96 | -0.1237 | 6.96 |
| Soho Global Health Tbk PT | 6.89tn | 325.04bn | 6.60tn | 2.41k | 20.30 | 2.65 | 16.78 | 0.9574 | 256.10 | 256.10 | 5,431.66 | 1,963.83 | 1.52 | 4.70 | 4.87 | 2,875,966,000.00 | 7.15 | -- | 12.94 | -- | 18.72 | -- | 4.72 | -- | 1.46 | -- | 0.0108 | -- | 14.80 | -- | 219.67 | -- | -- | -- |
| PT Industri Jamu dan Farmasi Sd Mncl Tbk | 3.87tn | 1.10tn | 25.20tn | 3.17k | 22.79 | 7.19 | 20.79 | 6.52 | 36.85 | 36.85 | 128.85 | 116.85 | 0.9486 | 3.41 | 5.72 | 1,220,948,000.00 | 27.11 | 25.92 | 31.27 | 29.54 | 55.95 | 55.08 | 28.58 | 27.98 | 3.05 | -- | 0.0007 | 93.06 | -3.87 | 8.47 | -12.39 | 15.66 | -12.18 | 20.46 |
